(MoneyNewsWire.Net, January 10, 2018 ) Rapid advancements in genetic engineering are boosting the growth of Aptamers Market
According to the report Aptamers Market, published by Market Data Forecast, the Global market is projected to reach USD 345.7 million by 2022, at a CAGR of 18% from 2017 to 2022
Aptamers are peptide molecules which can bind to target molecules such as proteins, lipids and nucleic acids. They can be used in the research purposes in drug development and in macromolecular drugs. They can used in enzyme inhibitions, alter protein expression and for detection of targeted molecules. If engineered or modified, they can have high specificity to target molecules and can be used to bind to cancer cells and to inhibit their activities.
Get a comprehensive overview of the Aptamers Market: https://www.marketdataforecast.com/market-reports/global-aptamers-market-1134/
Aptamers Market: Drivers & Restraints
Growing investments in the biotechnology and pharmaceutical industries, huge technological achievements in genetic engineering and the potential to create miraculous drugs are driving the market growth. Increasing applications of aptamers in cancer therapy and other diseases is also expected to propel the market growth.
However, strict regulations regarding the use of animals for aptamers extraction and unfavorable approval guidelines are inhibiting the market growth.
Get accurate market forecast and analysis on the Aptamers Market. Request a sample to stay up-to-date on the main trends affecting this market: https://www.marketdataforecast.com/market-reports/global-aptamers-market-1134/request-sample
Aptamers Market: Segmentation
Nucleic Acid Aptamers
Research and Development
By End User
Academic and Research Centers
Middle East & Africa
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at: https://www.marketdataforecast.com/market-reports/global-aptamers-market-1134/customize-report
Aptamers Market: Overview
Based on type, peptide aptamers hold the largest market share. It is due to their wide applications in inhibition. Nucleic acid aptamers are expected to grow rapidly due to increasing genetic engineering techniques to modify protein synthesis. Based on application, therapeutics development segment hold the largest market share due to the high demand for protein therapeutic drugs.
North America leads the Aptamers market. It is due to the high investments on aptamers research to develop therapeutic drugs and also due to the growing pharmaceutical and biotechnology industries. Asia Pacific is the fastest growing market due to the increasing awareness of aptamer drugs and increasing healthcare investments in this region.
Aptamers Market: Key Players
Major players in the Aptamers market are Aptus Biotech S.L., AM Biotechnologies, Aptamer Solutions Ltd., Aptagen, Aptamer Sciences Inc., Base Pair Biotechnologies Inc., SomaLogic Inc, TriLink BioTechnologies Inc., NeoVentures Biotechnology Inc. and Vivonics, Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast